IDiyas

For the Inventor, By the Inventor

Lianyungang, China

Fei Liu

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Jiangsu, CN (2013 - 2022)
  • Lianyungang, CN (2018 - 2023)

Company Filing History:

goldMedal16 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
silverMedal8 out of 33 
 
Centaurus Biopharma Co., Ltd.
 patents
bronzeMedal5 out of 26 
 
Lianyungang Runzhong Pharmaceutical Co., Ltd.
 patents
4. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):
1. 12371431 - Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor (2025-07-29),
2. 12358913 - Crystal of diarylthiohydantoin compound (2025-07-15),
3. 12358891 - Crystals of quinolone derivatives (2025-07-15),
4. 12319689 - Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor (2025-06-03),
5. 12187710 - Salt of Syk inhibitor and crystalline form thereof (2025-01-07),
6. 11773079 - Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine (2023-10-03),
7. 11279676 - Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof (2022-03-22),
8. 11098060 - Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof (2021-08-24),
9. 11021464 - Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt (2021-06-01),
10. 10858340 - Crystal of salt of quinazoline derivative (2020-12-08),
11. 10851071 - M-dihydroxybenzene derivative crystal and salt, and manufacturing method thereof (2020-12-01),
12. 10501468 - Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as MEK inhibitor (2019-12-10),
13. 10450328 - Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof (2019-10-22),
14. 10376512 - Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereof (2019-08-13),
15. 10231973 - Salts of quinazoline derivative and method for preparing the same (2019-03-19),

Title: The Innovative Journey of Inventor Fei Liu

Introduction: Fei Liu is a prominent inventor based in Lianyungang, China, known for his groundbreaking contributions to the field of medicine. With a total of 17 patents to his name, Liu has developed innovative compounds aimed at addressing critical health issues, especially in the realm of cancer treatment and androgen-mediated diseases.

Latest Patents: Among his latest patents is the "Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor." This patent discloses a compound that serves as a selective inhibitor for the BCL-2 protein, which is pivotal in treating anti-apoptotic BCL-2-related diseases, such as cancer. The patent includes details on the compound's formula, pharmaceutical composition, and its application in therapies. Another significant patent is related to a "Crystal of diarylthiohydantoin compound," which highlights a preparation method for this compound and its use in developing medicaments for diseases linked to androgen.

Career Highlights: Liu's career has been marked by his impressive work with notable pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His efforts in drug development and innovation have positioned him as a key player in his field, contributing significantly to advancements in pharmaceutical sciences.

Collaborations: Throughout his career, Liu has collaborated with talented individuals, including Xiquan Zhang and Yizhong Zhu. These partnerships have fostered a creative environment that has led to the successful development of complex medicinal compounds designed to combat significant health challenges.

Conclusion: Fei Liu's innovative spirit and dedication to advancing medical science through his patents are commendable. His work not only reflects a commitment to innovation but also showcases the potential of scientific inquiry in developing effective treatments. As he continues to explore new frontiers in medicine, Liu remains a valuable asset to the field and an inspiration to aspiring inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…